Get Quote

Keryx Biopharmaceuticals (NASDAQ:KERX)

CAPS Game Rating: 1 out of 5

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

Recs

0
Member Avatar TMFBiologyFool (99.13) Submitted: 05/04/2010 12:29:44 : Underperform Start Price: $3.28 KERX Score: -104.83

A 20% increase because of a fast-track designation? Really?

Report this Post Reply

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.